These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 39206385)

  • 1. Developmental endothelial locus 1: the present and future of an endogenous factor in vessels.
    Jiang D; Yue H; Liang WT; Wu Z
    Front Physiol; 2024; 15():1347888. PubMed ID: 39206385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDIL3/Del-1 prevents aortic dissection through enhancing internalization and degradation of apoptotic vascular smooth muscle cells.
    Yin Z; Zhang J; Zhao M; Liu J; Xu Y; Peng S; Pan W; Wei C; Zheng Z; Liu S; Qin JJ; Wan J; Wang M
    Autophagy; 2024 Jul; ():1-21. PubMed ID: 38873925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation.
    Klotzsche-von Ameln A; Cremer S; Hoffmann J; Schuster P; Khedr S; Korovina I; Troullinaki M; Neuwirth A; Sprott D; Chatzigeorgiou A; Economopoulou M; Orlandi A; Hain A; Zeiher AM; Deussen A; Hajishengallis G; Dimmeler S; Chavakis T; Chavakis E
    Thromb Haemost; 2017 Jun; 117(6):1150-1163. PubMed ID: 28447099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEL-1 promotes macrophage efferocytosis and clearance of inflammation.
    Kourtzelis I; Li X; Mitroulis I; Grosser D; Kajikawa T; Wang B; Grzybek M; von Renesse J; Czogalla A; Troullinaki M; Ferreira A; Doreth C; Ruppova K; Chen LS; Hosur K; Lim JH; Chung KJ; Grossklaus S; Tausche AK; Joosten LAB; Moutsopoulos NM; Wielockx B; Castrillo A; Korostoff JM; Coskun Ü; Hajishengallis G; Chavakis T
    Nat Immunol; 2019 Jan; 20(1):40-49. PubMed ID: 30455459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation.
    Failer T; Amponsah-Offeh M; Neuwirth A; Kourtzelis I; Subramanian P; Mirtschink P; Peitzsch M; Matschke K; Tugtekin SM; Kajikawa T; Li X; Steglich A; Gembardt F; Wegner AC; Hugo C; Hajishengallis G; Chavakis T; Deussen A; Todorov V; Kopaliani I
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35133978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RGD finger of Del-1 is a unique structural feature critical for integrin binding.
    Schürpf T; Chen Q; Liu JH; Wang R; Springer TA; Wang JH
    FASEB J; 2012 Aug; 26(8):3412-20. PubMed ID: 22601780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis.
    Kim DY; Lee SH; Fu Y; Jing F; Kim WY; Hong SB; Song JA; Choe H; Ryu HJ; Kim M; Lim D; Kim MS; Yun CO; Lee T; Hyun H; Choi EY
    Front Immunol; 2020; 11():68. PubMed ID: 32117240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEL-1-Regulated Immune Plasticity and Inflammatory Disorders.
    Hajishengallis G; Chavakis T
    Trends Mol Med; 2019 May; 25(5):444-459. PubMed ID: 30885428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia.
    Ho HK; Jang JJ; Kaji S; Spektor G; Fong A; Yang P; Hu BS; Schatzman R; Quertermous T; Cooke JP
    Circulation; 2004 Mar; 109(10):1314-9. PubMed ID: 14981004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental endothelial locus-1 modulates platelet-monocyte interactions and instant blood-mediated inflammatory reaction in islet transplantation.
    Kourtzelis I; Kotlabova K; Lim JH; Mitroulis I; Ferreira A; Chen LS; Gercken B; Steffen A; Kemter E; Klotzsche-von Ameln A; Waskow C; Hosur K; Chatzigeorgiou A; Ludwig B; Wolf E; Hajishengallis G; Chavakis T
    Thromb Haemost; 2016 Apr; 115(4):781-8. PubMed ID: 26676803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
    Zhao M; Zheng Z; Li C; Wan J; Wang M
    Front Immunol; 2022; 13():1053175. PubMed ID: 36518760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review.
    Li M; Zhong D; Li G
    Cell Mol Biol Lett; 2021 Jul; 26(1):31. PubMed ID: 34217213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof.
    Chavakis T
    Eur J Clin Invest; 2012 Jun; 42(6):686-91. PubMed ID: 22577952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of developmental endothelial locus-1 in a subset of macrophages for engulfment of apoptotic cells.
    Hanayama R; Tanaka M; Miwa K; Nagata S
    J Immunol; 2004 Mar; 172(6):3876-82. PubMed ID: 15004195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of leukocyte adhesion by developmental endothelial locus-1 (del-1).
    Choi EY
    Immune Netw; 2009 Oct; 9(5):153-7. PubMed ID: 20157603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of the homeostatic molecule Del-1 in endothelial cells and the periodontal tissue.
    Shin J; Hosur KB; Pyaram K; Jotwani R; Liang S; Chavakis T; Hajishengallis G
    Clin Dev Immunol; 2013; 2013():617809. PubMed ID: 24416060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Del-1 overexpression in endothelial cells increases vascular density in tissue-engineered implants containing endothelial cells and adipose-derived mesenchymal stromal cells.
    Ciucurel EC; Sefton MV
    Tissue Eng Part A; 2014 Apr; 20(7-8):1235-52. PubMed ID: 24151812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHEA Inhibits Leukocyte Recruitment through Regulation of the Integrin Antagonist DEL-1.
    Ziogas A; Maekawa T; Wiessner JR; Le TT; Sprott D; Troullinaki M; Neuwirth A; Anastasopoulou V; Grossklaus S; Chung KJ; Sperandio M; Chavakis T; Hajishengallis G; Alexaki VI
    J Immunol; 2020 Mar; 204(5):1214-1224. PubMed ID: 31980574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment.
    Choi EY; Chavakis E; Czabanka MA; Langer HF; Fraemohs L; Economopoulou M; Kundu RK; Orlandi A; Zheng YY; Prieto DA; Ballantyne CM; Constant SL; Aird WC; Papayannopoulou T; Gahmberg CG; Udey MC; Vajkoczy P; Quertermous T; Dimmeler S; Weber C; Chavakis T
    Science; 2008 Nov; 322(5904):1101-4. PubMed ID: 19008446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efferocytosis of vascular cells in cardiovascular disease.
    Cabrera JTO; Makino A
    Pharmacol Ther; 2022 Jan; 229():107919. PubMed ID: 34171333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.